Royalty Pharma reported cash from operations of $728.46M and free cash flow of $477.44M for the quarter ended Jun 2026, up 100.1% year over year. This cash flow statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||
| Net Income | 221.80M | 53.67M | 128.08M | 491.60M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M | 194.38M | 806.36M | 334.35M | 434.43M | 92.64M | 444.21M | 355.91M | 468.26M | 81.49M | |||||||||
| Gains from Investment SecuritiesGains Investment | 6.21M | 6.17M | 20.69M | 6.81M | 5.81M | 5.83M | 16.27M | 2.24M | 0.31M | 13.40M | 0.50M | 13.40M | 0.60M | 0.90M | 3.72M | 21.02M | |||||||||||||
| Asset Writedowns and ImpairmentWritedown | 69.40M | ||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | 469.76M | 489.96M | 460.27M | 574.95M | 538.83M | 569.93M | 1,033.84M | 607.82M | 573.52M | 772.63M | 664.64M | 658.21M | 703.61M | 742.52M | 596.08M | 363.98M | 702.62M | 827.15M | 718.23M | 728.46M | |||||||||
| Investing Activities | |||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 1,336.03M | 171.73M | 0.09M | 175.01M | 1,316.31M | 250.24M | 601.71M | 60.45M | 451.13M | 1,002.24M | 86.08M | 728.63M | 1,194.57M | 496.42M | 1.06M | 1.11M | 961.87M | 733.68M | 452.37M | 251.02M | |||||||||
| Acquisitions | 0.23M | ||||||||||||||||||||||||||||
| Divestments | 6.20M | 6.80M | 5.80M | 34.77M | 2.20M | 4.80M | 4.66M | 4.96M | 3.90M | 11.00M | 3.24M | 36.26M | 62.40M | 0.91M | 4.99M | 42.31M | -13.21M | ||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 624.45M | 104.72M | 274.61M | 251.30M | 150.80M | 115.64M | 24.39M | 1.44M | 2.88M | 2.88M | 12.59M | 12.59M | 2.88M | 2.88M | 2.88M | 4.32M | 4.32M | ||||||||||||
| Cash from Investing ActivitiesCash from Investing | -845.50M | -551.65M | 11.16M | -30.18M | -1425.15M | 414.74M | -558.53M | -63.43M | -450.66M | -1000.17M | -86.65M | -893.18M | -1192.70M | -505.59M | 503.92M | -311.98M | -958.31M | -847.80M | -477.87M | -229.72M | |||||||||
| Financing Activities | |||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.00M | -0.00M | -1.79M | -0.23M | -0.39M | ||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1,034.27M | -198.07M | -220.97M | -228.25M | -230.09M | -265.55M | -210.37M | -347.00M | -1359.49M | -231.89M | -212.00M | 1,156.61M | -325.50M | -257.96M | -941.30M | -507.81M | 562.74M | -299.60M | -272.67M | -273.15M | |||||||||
| Dividend Payments | |||||||||||||||||||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | 125.43M | -230.19M | 34.52M | 37.83M | 38.62M | 33.15M | 33.39M | 30.53M | 31.12M | 24.49M | 32.01M | 30.68M | 31.02M | 31.45M | 53.83M | 38.60M | 34.28M | 40.76M | 39.88M | 34.59M | |||||||||
| Additional items | |||||||||||||||||||||||||||||
| Change in Cash | 658.53M | -259.76M | 250.47M | 316.52M | -1116.41M | 719.12M | 264.94M | 197.39M | -1236.63M | -459.44M | 365.99M | 921.64M | -814.59M | -21.03M | 158.69M | -455.81M | 307.04M | -320.25M | -32.30M | 225.59M | |||||||||
| Free Cash FlowFCF | -866.27M | 318.22M | 460.19M | 399.94M | -777.48M | 319.69M | 432.13M | 547.37M | 122.39M | -229.61M | 578.55M | -70.42M | -490.96M | 246.11M | 595.02M | 362.87M | -259.26M | 93.46M | 265.87M | 477.44M | |||||||||
| Net Cash FlowNCF | 658.53M | -259.76M | 250.47M | 316.52M | -1116.41M | 719.12M | 264.94M | 197.39M | -1236.63M | -459.44M | 365.99M | 921.64M | -814.59M | -21.03M | 158.69M | -455.81M | 307.04M | -320.25M | -32.30M | 225.59M |